Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZYG11B | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | ZUFSP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ZSWIM5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ZSWIM4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | ZRANB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZPR1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | ZNF92 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ZNF891 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |